Risk of Cancer After Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rh-BMP-2)

STUDY DESIGN. Retrospective cohort study among Medicare beneficiaries with lumbar spinal fusion surgery. OBJECTIVE. To determine the risk of subsequent cancer among patients who received recombinant human bone morphogenic protein (rhBMP) at surgery compared with those who did not. SUMMARY OF BACKGRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Gregory S., Kou, Tzuyung Doug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006942/
https://www.ncbi.nlm.nih.gov/pubmed/23883824
http://dx.doi.org/10.1097/BRS.0b013e3182a3d3b4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006942/
https://www.ncbi.nlm.nih.gov/pubmed/23883824
http://dx.doi.org/10.1097/BRS.0b013e3182a3d3b4

Ejemplares similares